Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-9sONLfn1
September 14, 2023jessica-sacher
Phage therapy Clinical Trial Biotech news

Intralytix has announced the launch of a Phase 1/2a clinical trial of its VRELysin™ phage preparation to assess safety and efficacy in healthy and VRE-colonized subjects at UPMC in Pittsburgh, Pennsylvania.

Loading ...
No comments yet. Be the first to comment!